Original Research
Published on 06 Jan 2025
Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model
in Molecular Medicine for Cardiology
- 215 views